Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 4Prostatic Neoplasms 3Breast Neoplasms 3Vitamin D Deficiency 2Polycystic Ovary Syndrome 2Neoplasms 2Cardiovascular Diseases 2Vitamin D3 1Neuroma 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Breast Cancer and Large Operable Breast Cancer 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Insulin Resistance 1Fractures, Bone 1Colorectal Adenocarcinoma 1

Interventions

Ralfinamide 1Lidoderm 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neuroma × Cholecalciferol × Clear all
NCT04115982 2021-08-31

D3NERV

University Hospital, Caen

Phase 3 Unknown
72 enrolled

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡